Literature DB >> 16537431

A dopamine transporter gene functional variant associated with cocaine abuse in a Brazilian sample.

Camila Guindalini1, Mark Howard, Kate Haddley, Ronaldo Laranjeira, David Collier, Nik Ammar, Ian Craig, Colin O'Gara, Vivian J Bubb, Tiffany Greenwood, John Kelsoe, Phil Asherson, Robin M Murray, Adauto Castelo, John P Quinn, Homero Vallada, Gerome Breen.   

Abstract

The dopamine (DA) transporter DAT1 is a major target bound by cocaine in brain. We examined the influence of functional genetic variants in DAT1 on cocaine addiction. Repeat polymorphisms, including a 30-bp variable-number tandem repeat (VNTR) in intron 8 (Int8 VNTR) with two common alleles, were genotyped in cocaine-dependent abusers (n = 699) and in controls with no past history of drug abuse (n = 866) from São Paulo, Brazil. Positive association was observed with allele 3 of the Int8 VNTR and cocaine abuse (allele odds ratio = 1.2, 95% confidence interval = 1.01-1.37, P = 0.036; 3/3 homozygote odds ratio = 1.45, 95% confidence interval = 1.18-1.78, P = 0.0008). Population stratification was assessed and did not affect the results. Haplotypic analyses using additional polymorphisms indicated that the Int8 VNTR is responsible for the observed association. Functional analyses in reporter-gene constructs, demonstrated that allele 3 mediates significant (P < 0.05) but small reduced expression compared with the "protective" allele 2. This difference increased when 1 and 10 muM cocaine was added to the cell culture ( approximately 40% reduction of the 3 allele expression versus the 2 allele). The 3 allele also demonstrated approximately 3-fold-increased expression over the 2 allele in response to KCl plus forskolin challenge. We demonstrate a robust association between cocaine dependence and a VNTR allele in SLC6A3, conferring a small but detectable effect, and we show that this VNTR may be functional. This study suggests that DAT1 gene variation may play a role in cocaine dependence etiology.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16537431      PMCID: PMC1450209          DOI: 10.1073/pnas.0504789103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  46 in total

1.  The human genome browser at UCSC.

Authors:  W James Kent; Charles W Sugnet; Terrence S Furey; Krishna M Roskin; Tom H Pringle; Alan M Zahler; David Haussler
Journal:  Genome Res       Date:  2002-06       Impact factor: 9.043

2.  Cocaine receptors on dopamine transporters are related to self-administration of cocaine.

Authors:  M C Ritz; R J Lamb; S R Goldberg; M J Kuhar
Journal:  Science       Date:  1987-09-04       Impact factor: 47.728

3.  Novel method for identifying sequence-specific DNA-binding proteins.

Authors:  D Levens; P M Howley
Journal:  Mol Cell Biol       Date:  1985-09       Impact factor: 4.272

4.  A polymorphic microsatellite that mediates induction of PIG3 by p53.

Authors:  Ana Contente; Alexandra Dittmer; Manuela C Koch; Judith Roth; Matthias Dobbelstein
Journal:  Nat Genet       Date:  2002-02-04       Impact factor: 38.330

5.  The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression.

Authors:  S Fuke; S Suo; N Takahashi; H Koike; N Sasagawa; S Ishiura
Journal:  Pharmacogenomics J       Date:  2001       Impact factor: 3.550

6.  An activator element within the preprotachykinin-A promoter.

Authors:  C F Morrison; J McAllister; S P Dobson; P K Mulderry; J P Quinn
Journal:  Mol Cell Neurosci       Date:  1994-04       Impact factor: 4.314

7.  Serotonin transporter polymorphisms and measures of impulsivity, aggression, and sensation seeking among African-American cocaine-dependent individuals.

Authors:  Ashwin A Patkar; Wade H Berrettini; Margret Hoehe; Charles C Thornton; Edward Gottheil; Kevin Hill; Stephen P Weinstein
Journal:  Psychiatry Res       Date:  2002-06-01       Impact factor: 3.222

8.  Involvement of an upstream stimulatory factor as well as cAMP-responsive element-binding protein in the activation of brain-derived neurotrophic factor gene promoter I.

Authors:  Akiko Tabuchi; Hidemichi Sakaya; Tomochika Kisukeda; Hiroshi Fushiki; Masaaki Tsuda
Journal:  J Biol Chem       Date:  2002-07-11       Impact factor: 5.157

9.  Familial transmission of substance use disorders.

Authors:  K R Merikangas; M Stolar; D E Stevens; J Goulet; M A Preisig; B Fenton; H Zhang; S S O'Malley; B J Rounsaville
Journal:  Arch Gen Psychiatry       Date:  1998-11

10.  Genetic association between dopamine transporter protein alleles and cocaine-induced paranoia.

Authors:  J Gelernter; H R Kranzler; S L Satel; P A Rao
Journal:  Neuropsychopharmacology       Date:  1994-11       Impact factor: 7.853

View more
  62 in total

1.  Human dopamine transporter gene: differential regulation of 18-kb haplotypes.

Authors:  Ying Zhao; Nian Xiong; Yang Liu; Yanhong Zhou; Nuomin Li; Hong Qing; Zhicheng Lin
Journal:  Pharmacogenomics       Date:  2013-09       Impact factor: 2.533

2.  A population-based Swedish Twin and Sibling Study of cannabis, stimulant and sedative abuse in men.

Authors:  Kenneth S Kendler; Henrik Ohlsson; Hermine H Maes; Kristina Sundquist; Paul Lichtenstein; Jan Sundquist
Journal:  Drug Alcohol Depend       Date:  2015-01-28       Impact factor: 4.492

3.  Association analysis between polymorphisms in the conserved dopamine neurotrophic factor (CDNF) gene and cocaine dependence.

Authors:  Falk W Lohoff; Paul J Bloch; Thomas N Ferraro; Wade H Berrettini; Helen M Pettinati; Charles A Dackis; Charles P O'Brien; Kyle M Kampman; David W Oslin
Journal:  Neurosci Lett       Date:  2009-02-21       Impact factor: 3.046

Review 4.  Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine.

Authors:  Colin N Haile; Thomas R Kosten; Therese A Kosten
Journal:  Am J Drug Alcohol Abuse       Date:  2009       Impact factor: 3.829

5.  Predicting childhood effortful control from interactions between early parenting quality and children's dopamine transporter gene haplotypes.

Authors:  Yi Li; Michael J Sulik; Nancy Eisenberg; Tracy L Spinrad; Kathryn Lemery-Chalfant; Daryn A Stover; Brian C Verrelli
Journal:  Dev Psychopathol       Date:  2015-04-30

6.  Carriers of a common variant in the dopamine transporter gene have greater dementia risk, cognitive decline, and faster ventricular expansion.

Authors:  Florence F Roussotte; Boris A Gutman; Derrek P Hibar; Sarah K Madsen; Katherine L Narr; Paul M Thompson
Journal:  Alzheimers Dement       Date:  2014-12-10       Impact factor: 21.566

7.  Association of dopamine transporter gene variants with childhood ADHD features in bipolar disorder.

Authors:  Tiffany A Greenwood; Eun-Jeong Joo; Tatyana Shekhtman; A Dessa Sadovnick; Ronald A Remick; Paul E Keck; Susan L McElroy; John R Kelsoe
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2012-12-19       Impact factor: 3.568

8.  Genomic features of the human dopamine transporter gene and its potential epigenetic States: implications for phenotypic diversity.

Authors:  Elena Shumay; Joanna S Fowler; Nora D Volkow
Journal:  PLoS One       Date:  2010-06-10       Impact factor: 3.240

Review 9.  Poor response inhibition: at the nexus between substance abuse and attention deficit/hyperactivity disorder.

Authors:  Stephanie M Groman; Alex S James; J David Jentsch
Journal:  Neurosci Biobehav Rev       Date:  2008-08-22       Impact factor: 8.989

10.  Combinatorial interaction between two human serotonin transporter gene variable number tandem repeats and their regulation by CTCF.

Authors:  Fahad R Ali; Sylvia A Vasiliou; Kate Haddley; Ursula M Paredes; Julian C Roberts; Fabio Miyajima; Elena Klenova; Vivien J Bubb; John P Quinn
Journal:  J Neurochem       Date:  2009-10-26       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.